• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody

  2026-08-14

  Use this Alexa Fluor 488 conjugated secondary antibody to convert goat-primary immunoassays into sensitive, image-ready workflows across fluorescence microscopy, Western blotting, tissue staining, and flow cytometry. The article translates FXR-driven replication-organelle biology into practical assay design, controls, and troubleshooting decisions.

• iRhom2 Links Olfactory Receptors to Adaptation

  2026-08-13

  Azzopardi and colleagues identify iRhom2 as a distinctive component of olfactory sensory neurons and connect its expression with odorant receptor regulation and activity-dependent adaptation. Their combination of mouse genetics, transcriptomics, spatial analysis, and an ectopic receptor-signaling model supports an iRhom2/ADAM17 feedback mechanism, while also defining important limits on causal interpretation.

• Pazopanib Hydrochloride: Mechanism & Benchmarks

  2026-08-13

  Pazopanib Hydrochloride (GW786034) is a multi-target receptor tyrosine kinase inhibitor used in oncology research and approved clinical indications. This evidence-focused guide separates kinase potency, tumor-model activity, clinical scope, and viability-assay interpretation.

• Dasatinib and the SNAI1–EphA2 Translational Axis

  2026-08-12

  A translational framework for using Dasatinib (BMS-354825) to interrogate Src-linked signaling, EMT, stemness, and metastatic phenotypes emerging from the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors.

• CA-074: A Selective Cathepsin B Inhibitor

  2026-08-12

  CA-074 enables mechanism-focused studies of cathepsin B in cancer metastasis, neurotoxicity, immune response modulation, and plant senescence. Its strong biochemical selectivity makes it useful for separating cathepsin B activity from broader cysteine-protease effects, provided assay context and cellular exposure are controlled.

• iRhom2 in Olfaction: Receptor Regulation and Adaptation

  2026-08-11

  Azzopardi and colleagues identify iRhom2 as a distinctive component of olfactory sensory neurons and connect its expression with odorant receptor regulation and activity-dependent adaptation. Their combination of knockout analysis, transcriptomics, spatial validation, and heterologous receptor signaling suggests that odor stimulation may engage an iRhom2–ADAM17 pathway that feeds back on olfactory gene expression.

• Reactive Oxygen Species Assay Kit (DHE)

  2026-08-11

  This scenario-driven guide explains how to design, optimize, and interpret live-cell intracellular superoxide measurements with Reactive Oxygen Species (ROS) Assay Kit (DHE), SKU K2066. It connects practical oxidative stress assay decisions with redox signaling and apoptosis research while distinguishing product specifications from workflow recommendations.

• Measuring Drug Response Beyond Viability

  2026-08-10

  Hannah Schwartz’s dissertation separates relative viability from fractional viability to clarify how cancer drugs inhibit proliferation and induce cell death. Its central implication is methodological: in vitro drug-response studies should treat growth suppression, killing, and response timing as related but nonidentical measurements.

• CHIR 99021 Trihydrochloride in Organoid Design

  2026-08-09

  CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for dissecting stem-cell state, Wnt-linked signaling, and glucose metabolism. This guide connects its molecular pharmacology with tunable intestinal organoid design and endpoint-aware assay planning.

• Resiquimod (R-848): From TLR Signals to Assays

  2026-08-08

  Resiquimod (R-848) is a dual TLR7/8 agonist that links innate immune response modulation with spatially controlled tumor-ablation research. This guide focuses on how to design, control, and interpret assays built around its timing, localization, and immune readouts.

• PD 0332991: A Cell-State Lens on Resistance

  2026-08-07

  PD 0332991 and Palbociclib HCl offer a selective way to interrogate CDK4/6–Rb–E2F control of proliferation. This article translates cisplatin-resistance findings into a resistance-aware assay framework that separates cytostasis, apoptosis, and tumor growth suppression.

• Anlotinib Hydrochloride: Applied Workflows for Multi-Target

  2026-08-07

  Anlotinib hydrochloride is a next-generation multi-target tyrosine kinase inhibitor with superior potency and selectivity for angiogenesis and tumor biology research. This guide translates reference breakthroughs and protocol data into actionable workflows, troubleshooting steps, and strategic insights, empowering cancer researchers to maximize reproducibility and discovery impact.

• Lipo3K Transfection Reagent: Enabling Next-Gen Nucleic Acid

  2026-08-06

  Discover how Lipo3K Transfection Reagent empowers high-efficiency nucleic acid delivery—even in difficult-to-transfect cells—while advancing assay design for emerging nucleic acid therapeutics. Explore its unique mechanism, protocol nuances, and insights from recent stimulus-responsive oligonucleotide research.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-08-06

  This study presents a streamlined 13-step protocol for synthesizing deuterium-labeled degarelix acetate, a potent GnRH receptor antagonist. The method enables reliable isotope incorporation, facilitating advanced pharmacokinetic and metabolic studies relevant to androgen-related diseases.

• EdU Flow Cytometry Assay Kits (Cy5): Beyond S-Phase Detectio

  2026-08-05

  Discover how EdU Flow Cytometry Assay Kits (Cy5) enable advanced, artifact-free analysis of cell proliferation, with unique insights into m7G-regulated cell cycle control. Learn why this CuAAC-based technology is essential for precise DNA synthesis detection in modern research.

7992 records 3/533 page Previous Next 12345 下5页 Last page